stockrow
Friday 6 November 2026
Export HROW’s income statement to Excel — free account
Harrow, Inc.
HROW Healthcare Drug Manufacturers Specialty & Generic
Harrow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $272.3 million, up 36.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −428.6%
- Free cash flow
- −838.8%
- Total debt
- +659.7%
Quarter to June 2026, against a year earlier
26.63
0.59
+2.27%
Follow HROW
Alert me
Harrow, Inc. (HROW) P/E ratio
Harrow, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 389× (December 2019) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 389× | 4,412.13% |
| FY2018 | 8.6× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 389×
Ten-year median
0.0×
Current reading's percentile
85
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| HROW Harrow, Inc. | n/m |
| ALVO Alvotech compare | n/m |
| AMPH Amphastar Pharmaceuticals, Inc. compare | 12.3× |
| ANIP ANI Pharmaceuticals, Inc. compare | 13.3× |
| PAHC Phibro Animal Health Corporation compare | 14.0× |
| COLL Collegium Pharmaceutical, Inc. compare | 20.5× |
| CRON Cronos Group Inc. compare | 21.9× |
| ETON Eton Pharmaceuticals, Inc. compare | 26.8× |
| PCRX Pacira BioSciences, Inc. compare | 38.4× |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)